chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Glucose tolerance test, Maternal exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included Artificial insemination (IUI). Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for Anxiety, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 04-Jul-2020 and the estimated date of delivery was 09-Apr-2021. On 06-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, Glucose tolerance test: normal (normal) normal. In 2020, Ultrasound scan: normal (normal) normal. On 31-Jul-2021, Pregnancy test: positive (Positive) Positive.         Treatment information was not provided. Estimated date of conception was on 17 Jul 2021. It was reported that there was maternal history of subfertility wherein intrauterine insemination was performed.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Diarrhoea
Clinical narrative: Bloating; For the past 15 days constant diarrhea; For the past 15 days abdominal pain and cramping; Pretty bad abdominal pain; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Pretty bad abdominal pain), DIARRHOEA (Diarrhea), ABDOMINAL DISTENSION (Bloating), DIARRHOEA (For the past 15 days constant diarrhea) and ABDOMINAL PAIN (For the past 15 days abdominal pain and cramping) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced ABDOMINAL PAIN (Pretty bad abdominal pain) and DIARRHOEA (Diarrhea). On 21-Feb-2021, the patient experienced ABDOMINAL DISTENSION (Bloating), DIARRHOEA (For the past 15 days constant diarrhea) and ABDOMINAL PAIN (For the past 15 days abdominal pain and cramping). On 12-Feb-2021, ABDOMINAL PAIN (Pretty bad abdominal pain) and DIARRHOEA (Diarrhea) had resolved. At the time of the report, ABDOMINAL DISTENSION (Bloating), DIARRHOEA (For the past 15 days constant diarrhea) and ABDOMINAL PAIN (For the past 15 days abdominal pain and cramping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Lab Test was performed and patient was normal.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Headache, Pain
Clinical narrative: pain; face was blood shot red; dizziness; headache (felt like head was going to explode); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), ERYTHEMA (face was blood shot red), DIZZINESS (dizziness) and HEADACHE (headache (felt like head was going to explode)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, MONTELUKAST SODIUM (SINGULAIR) and ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (pain), ERYTHEMA (face was blood shot red), DIZZINESS (dizziness) and HEADACHE (headache (felt like head was going to explode)). At the time of the report, PAIN (pain), ERYTHEMA (face was blood shot red), DIZZINESS (dizziness) and HEADACHE (headache (felt like head was going to explode)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: rash on chest; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on chest) and VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history information provided.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and METOPROLOL for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH (rash on chest) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 08-Mar-2021, RASH (rash on chest) and VOMITING (vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Peripheral swelling, Pruritus, Swelling
Clinical narrative: Itching; Big red spot; Swollen; Hot; Swollen left hand; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), ERYTHEMA (Big red spot), SWELLING (Swollen), BURNING SENSATION (Hot) and PERIPHERAL SWELLING (Swollen left hand) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASCORBIC ACID, ZINC (VITAMIN C + ZINC) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen left hand). On 07-Mar-2021, the patient experienced ERYTHEMA (Big red spot), SWELLING (Swollen) and BURNING SENSATION (Hot). On 08-Mar-2021, the patient experienced PRURITUS (Itching). On 06-Mar-2021, PERIPHERAL SWELLING (Swollen left hand) had resolved. At the time of the report, PRURITUS (Itching), ERYTHEMA (Big red spot), SWELLING (Swollen) and BURNING SENSATION (Hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included ice.   This case was linked to MOD-2021-037454 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Achy, sore of lymphnodes; Lymph nodes swollen under the armpit and down the side to rib cage; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (Achy, sore of lymphnodes) and LYMPHADENOPATHY (Lymph nodes swollen under the armpit and down the side to rib cage) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included Hysterotomy (Patient had a hysterotomy in July).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced LYMPH NODE PAIN (Achy, sore of lymphnodes) and LYMPHADENOPATHY (Lymph nodes swollen under the armpit and down the side to rib cage). The patient was treated with PARACETAMOL (TYLENOL) on 04-Mar-2021 at a dose of As needed. At the time of the report, LYMPH NODE PAIN (Achy, sore of lymphnodes) and LYMPHADENOPATHY (Lymph nodes swollen under the armpit and down the side to rib cage) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not provided.  Treatment information also included cold compress on injection site.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in both legs; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Pain in both legs) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in both legs). The patient was treated with HISTAMINE HYDROCHLORIDE (AUSTRALIAN DREAM PAIN RELIEVING ARTHRITIS) for Pain legs, at a dose of UNK, qd and EMU OIL, TROLAMINE SALICYLATE (BLUE EMU CONTINUOUS PAIN RELIEF) for Pain legs, at a dose of UNK, qd. At the time of the report, PAIN IN EXTREMITY (Pain in both legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Hot rash below the injection site; swelling spread down to the elbow; Both shots still itch and and feels scratchy at the injection sites; Pain at the injection site; Red huge swelling at the injection site; Chills; Headache; Red hot rash below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot rash below the injection site), VACCINATION SITE SWELLING (swelling spread down to the elbow), VACCINATION SITE PRURITUS (Both shots still itch and and feels scratchy at the injection sites), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE ERYTHEMA (Red huge swelling at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Neuropathy and Blood pressure. Concomitant products included BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE (BISOPROLOL /HCTZ) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot rash below the injection site), VACCINATION SITE SWELLING (swelling spread down to the elbow), VACCINATION SITE PRURITUS (Both shots still itch and and feels scratchy at the injection sites), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red huge swelling at the injection site), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE RASH (Red hot rash below the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at a dose of 1 dosage form once a day; PARACETAMOL (TYLENOL) at a dose of 1 dosage form once a day and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot rash below the injection site), VACCINATION SITE SWELLING (swelling spread down to the elbow), VACCINATION SITE PRURITUS (Both shots still itch and and feels scratchy at the injection sites), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red huge swelling at the injection site), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE RASH (Red hot rash below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant products also included medication for diabetes, blood pressure and neuropathy.   This case was linked to MOD-2021-274013 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up received and Event- vaccination site pruritus and concomitant medications were added.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot rash below the injection site; swelling spread down to the elbow; Both shots still itch and and feels scratchy at the injection sites; Pain at the injection site; Red huge swelling at the injection site; Chills; Headache; Red hot rash below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot rash below the injection site), VACCINATION SITE SWELLING (swelling spread down to the elbow), VACCINATION SITE PRURITUS (Both shots still itch and and feels scratchy at the injection sites), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE ERYTHEMA (Red huge swelling at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Neuropathy and Blood pressure. Concomitant products included BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE (BISOPROLOL /HCTZ) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot rash below the injection site), VACCINATION SITE SWELLING (swelling spread down to the elbow), VACCINATION SITE PRURITUS (Both shots still itch and and feels scratchy at the injection sites), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red huge swelling at the injection site), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE RASH (Red hot rash below the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at a dose of 1 dosage form once a day; PARACETAMOL (TYLENOL) at a dose of 1 dosage form once a day and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot rash below the injection site), VACCINATION SITE SWELLING (swelling spread down to the elbow), VACCINATION SITE PRURITUS (Both shots still itch and and feels scratchy at the injection sites), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Red huge swelling at the injection site), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE RASH (Red hot rash below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant products also included medication for diabetes, blood pressure and neuropathy.   This case was linked to MOD-2021-274013 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up received and Event- vaccination site pruritus and concomitant medications were added.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Rhinorrhoea, Vaccination site erythema, Vaccination site haematoma
Clinical narrative: Snot with blood; Red at injection site; Nose running; Tired; Slight headache; Sore arm at in the injection; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Nose running), VACCINATION SITE HAEMATOMA (Snot with blood), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (Sore arm at in the injection) and HEADACHE (Slight headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at in the injection). On 06-Feb-2021, the patient experienced HEADACHE (Slight headache). On 07-Feb-2021, the patient experienced RHINORRHOEA (Nose running) and FATIGUE (Tired). On an unknown date, the patient experienced VACCINATION SITE HAEMATOMA (Snot with blood) and VACCINATION SITE ERYTHEMA (Red at injection site). At the time of the report, RHINORRHOEA (Nose running), VACCINATION SITE HAEMATOMA (Snot with blood), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (Sore arm at in the injection), HEADACHE (Slight headache) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Snot with blood; Red at injection site; Nose running; Tired; Slight headache; Sore arm at in the injection; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Nose running), VACCINATION SITE HAEMATOMA (Snot with blood), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (Sore arm at in the injection) and HEADACHE (Slight headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at in the injection). On 06-Feb-2021, the patient experienced HEADACHE (Slight headache). On 07-Feb-2021, the patient experienced RHINORRHOEA (Nose running) and FATIGUE (Tired). On an unknown date, the patient experienced VACCINATION SITE HAEMATOMA (Snot with blood) and VACCINATION SITE ERYTHEMA (Red at injection site). At the time of the report, RHINORRHOEA (Nose running), VACCINATION SITE HAEMATOMA (Snot with blood), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (Sore arm at in the injection), HEADACHE (Slight headache) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: red huge swelling at the injection site; injection site pain; chills; headache; hot rash; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (red huge swelling at the injection site), INJECTION SITE PAIN (injection site pain), CHILLS (chills), HEADACHE (headache) and INJECTION SITE RASH (hot rash) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (red huge swelling at the injection site), INJECTION SITE PAIN (injection site pain), CHILLS (chills), HEADACHE (headache) and INJECTION SITE RASH (hot rash). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form once a day and NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form once a day. At the time of the report, INJECTION SITE SWELLING (red huge swelling at the injection site), INJECTION SITE PAIN (injection site pain), CHILLS (chills), HEADACHE (headache) and INJECTION SITE RASH (hot rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included medication for diabetes, blood pressure and neuropathy.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: Swollen; red; hard; Headache; arm was a little tender; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (arm was a little tender), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE INDURATION (hard) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE, MULTIVITAMIN [VITAMINS NOS], ACETYLSALICYLIC ACID (BABY ASPIRIN), ASCORBIC ACID (VITAMIN C ACID) and CALCIUM for an unknown indication.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE PAIN (arm was a little tender). On 05-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE INDURATION (hard). At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (arm was a little tender), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE INDURATION (hard) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No treatment reported.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 36-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 25-Jul-2020 and the estimated date of delivery was 01-Apr-2021. On 18-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 18-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Aug-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Previous pregnancy end date included 24-Jan-2018 with live birth. On an unknown date ultrasound , glucose test were done showed normal findings. No treatment information provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Eye swelling, Fatigue, Headache
Clinical narrative: Left eye was slightly swollen; Soreness at her nose; Diarrhea; Nasal congestion; Fast pulse; Nausea; Headache; Fatigue; Muscle pains; Chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Left eye was slightly swollen), HEART RATE INCREASED (Fast pulse), DIARRHOEA (Diarrhea), NASAL CONGESTION (Nasal congestion) and NASAL DISCOMFORT (Soreness at her nose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Mitral valve prolapse, MGUS, Overactive bladder, Breast cancer stage I, Lactose intolerance and Thyroid disorder NOS. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), MOMETASONE FUROATE, NADOLOL (CORGARD), AMLODIPINE BESILATE (LODIPINE [AMLODIPINE BESILATE]), SOLIFENACIN SUCCINATE (VESICARE), PHYTOSTEROLS NOS (CHOLESTOFF ORIGINAL) and ANASTROZOLE (ANASTRAZOLE DENK) for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced HEART RATE INCREASED (Fast pulse), NASAL CONGESTION (Nasal congestion), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle pains) and CHILLS (Chills). On 28-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On 06-Mar-2021, the patient experienced NASAL DISCOMFORT (Soreness at her nose). On 07-Mar-2021, the patient experienced EYE SWELLING (Left eye was slightly swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PREDNISONE at a dose of Taken 2 pills.. On 27-Feb-2021, NASAL CONGESTION (Nasal congestion), FATIGUE (Fatigue), MYALGIA (Muscle pains) and CHILLS (Chills) had resolved. On 28-Feb-2021, HEART RATE INCREASED (Fast pulse) and DIARRHOEA (Diarrhea) had resolved. On 01-Mar-2021, HEADACHE (Headache) had resolved. On 06-Mar-2021, NASAL DISCOMFORT (Soreness at her nose) had resolved. At the time of the report, EYE SWELLING (Left eye was slightly swollen) and NAUSEA (Nausea) outcome was unknown.            The patient's medical history also included dermatological filler injected belowboth eyes one or one and half years ago.    Most recent FOLLOW-UP information incorporated above includes: On 14-Mar-2021: Follow up received on 14-MAR-2021, contains information such as, she has a swelling under her left eye that swelling started a week and a dayafter 2nd shot, taken diphenhydramine and two prednisone pills.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Myalgia, Nasal congestion, Nasal discomfort, Nausea
Clinical narrative: Left eye was slightly swollen; Soreness at her nose; Diarrhea; Nasal congestion; Fast pulse; Nausea; Headache; Fatigue; Muscle pains; Chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Left eye was slightly swollen), HEART RATE INCREASED (Fast pulse), DIARRHOEA (Diarrhea), NASAL CONGESTION (Nasal congestion) and NASAL DISCOMFORT (Soreness at her nose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Mitral valve prolapse, MGUS, Overactive bladder, Breast cancer stage I, Lactose intolerance and Thyroid disorder NOS. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), MOMETASONE FUROATE, NADOLOL (CORGARD), AMLODIPINE BESILATE (LODIPINE [AMLODIPINE BESILATE]), SOLIFENACIN SUCCINATE (VESICARE), PHYTOSTEROLS NOS (CHOLESTOFF ORIGINAL) and ANASTROZOLE (ANASTRAZOLE DENK) for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced HEART RATE INCREASED (Fast pulse), NASAL CONGESTION (Nasal congestion), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle pains) and CHILLS (Chills). On 28-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On 06-Mar-2021, the patient experienced NASAL DISCOMFORT (Soreness at her nose). On 07-Mar-2021, the patient experienced EYE SWELLING (Left eye was slightly swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PREDNISONE at a dose of Taken 2 pills.. On 27-Feb-2021, NASAL CONGESTION (Nasal congestion), FATIGUE (Fatigue), MYALGIA (Muscle pains) and CHILLS (Chills) had resolved. On 28-Feb-2021, HEART RATE INCREASED (Fast pulse) and DIARRHOEA (Diarrhea) had resolved. On 01-Mar-2021, HEADACHE (Headache) had resolved. On 06-Mar-2021, NASAL DISCOMFORT (Soreness at her nose) had resolved. At the time of the report, EYE SWELLING (Left eye was slightly swollen) and NAUSEA (Nausea) outcome was unknown.            The patient's medical history also included dermatological filler injected belowboth eyes one or one and half years ago.    Most recent FOLLOW-UP information incorporated above includes: On 14-Mar-2021: Follow up received on 14-MAR-2021, contains information such as, she has a swelling under her left eye that swelling started a week and a dayafter 2nd shot, taken diphenhydramine and two prednisone pills.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Lethargy, Myalgia
Clinical narrative: Swollen arm; Red arm; Itchiness on arm; Fever went to 100F; Chills; Body aches; Headache in front of her head; Didn't want to eat anything; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE PRURITUS (Itchiness on arm), PYREXIA (Fever went to 100F) and CHILLS (Chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE PRURITUS (Itchiness on arm), PYREXIA (Fever went to 100F), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache in front of her head), LETHARGY (Didn't want to eat anything) and ASTHENIA (Felt weak). At the time of the report, PERIPHERAL SWELLING (Swollen arm) was resolving, VACCINATION SITE ERYTHEMA (Red arm) and VACCINATION SITE PRURITUS (Itchiness on arm) had not resolved and PYREXIA (Fever went to 100F), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache in front of her head), LETHARGY (Didn't want to eat anything) and ASTHENIA (Felt weak) outcome was unknown.            The concomitant medication was not provided. The treatment information was not reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Swollen arm; Red arm; Itchiness on arm; Fever went to 100F; Chills; Body aches; Headache in front of her head; Didn't want to eat anything; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE PRURITUS (Itchiness on arm), PYREXIA (Fever went to 100F) and CHILLS (Chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE ERYTHEMA (Red arm), VACCINATION SITE PRURITUS (Itchiness on arm), PYREXIA (Fever went to 100F), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache in front of her head), LETHARGY (Didn't want to eat anything) and ASTHENIA (Felt weak). At the time of the report, PERIPHERAL SWELLING (Swollen arm) was resolving, VACCINATION SITE ERYTHEMA (Red arm) and VACCINATION SITE PRURITUS (Itchiness on arm) had not resolved and PYREXIA (Fever went to 100F), CHILLS (Chills), MYALGIA (Body aches), HEADACHE (Headache in front of her head), LETHARGY (Didn't want to eat anything) and ASTHENIA (Felt weak) outcome was unknown.            The concomitant medication was not provided. The treatment information was not reported.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hot flush, Pain in extremity
Clinical narrative: Warm legs; Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Warm legs) and PAIN IN EXTREMITY (Little sore arm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included INSULIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced HOT FLUSH (Warm legs) and PAIN IN EXTREMITY (Little sore arm). At the time of the report, HOT FLUSH (Warm legs) and PAIN IN EXTREMITY (Little sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included unspecified blood pressure medications No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: overall body aches; headache; really tired; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever), MYALGIA (overall body aches), HEADACHE (headache) and FATIGUE (really tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included LEVOTHYROXINE, SIMVASTATIN and COENZYME Q10 [UBIDECARENONE] for an unknown indication.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (fever). On 04-Mar-2021, the patient experienced MYALGIA (overall body aches), HEADACHE (headache) and FATIGUE (really tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 04-Mar-2021, CHILLS (Chills), PYREXIA (fever), MYALGIA (overall body aches), HEADACHE (headache) and FATIGUE (really tired) had resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Influenza like illness
Clinical narrative: Near syncope; feeling lightheaded/ dizziness; flue like symptoms; chills; headache; muscle aches/ body aches; fatigue; fever of 101°F; nausea; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (flue like symptoms), PRESYNCOPE (Near syncope), DIZZINESS (feeling lightheaded/ dizziness), MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and CHILLS (chills) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (cephalosporins) and Drug allergy (sulfa drugs). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-Jun-2020 to an unknown date for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 19-Jun-2021. On 02-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 01-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (flue like symptoms), DIZZINESS (feeling lightheaded/ dizziness), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches/ body aches), FATIGUE (fatigue), PYREXIA (fever of 101°F) and NAUSEA (nausea). On 03-Mar-2021, the patient experienced PRESYNCOPE (Near syncope). On 03-Mar-2021, CHILLS (chills) and PYREXIA (fever of 101°F) had resolved. On 11-Mar-2021, INFLUENZA LIKE ILLNESS (flue like symptoms), DIZZINESS (feeling lightheaded/ dizziness), HEADACHE (headache), MYALGIA (muscle aches/ body aches) and NAUSEA (nausea) had resolved. At the time of the report, PRESYNCOPE (Near syncope) and FATIGUE (fatigue) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches/ body aches), FATIGUE (fatigue), PYREXIA (fever of 101°F) and NAUSEA (nausea) to be probably related. No further causality assessments were provided for INFLUENZA LIKE ILLNESS (flue like symptoms), PRESYNCOPE (Near syncope), DIZZINESS (feeling lightheaded/ dizziness) and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy).    No treatment information was provided
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Myalgia, Nausea, Presyncope, Pyrexia
Clinical narrative: Near syncope; feeling lightheaded/ dizziness; flue like symptoms; chills; headache; muscle aches/ body aches; fatigue; fever of 101°F; nausea; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (flue like symptoms), PRESYNCOPE (Near syncope), DIZZINESS (feeling lightheaded/ dizziness), MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and CHILLS (chills) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (cephalosporins) and Drug allergy (sulfa drugs). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-Jun-2020 to an unknown date for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 19-Jun-2021. On 02-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 01-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (flue like symptoms), DIZZINESS (feeling lightheaded/ dizziness), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches/ body aches), FATIGUE (fatigue), PYREXIA (fever of 101°F) and NAUSEA (nausea). On 03-Mar-2021, the patient experienced PRESYNCOPE (Near syncope). On 03-Mar-2021, CHILLS (chills) and PYREXIA (fever of 101°F) had resolved. On 11-Mar-2021, INFLUENZA LIKE ILLNESS (flue like symptoms), DIZZINESS (feeling lightheaded/ dizziness), HEADACHE (headache), MYALGIA (muscle aches/ body aches) and NAUSEA (nausea) had resolved. At the time of the report, PRESYNCOPE (Near syncope) and FATIGUE (fatigue) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches/ body aches), FATIGUE (fatigue), PYREXIA (fever of 101°F) and NAUSEA (nausea) to be probably related. No further causality assessments were provided for INFLUENZA LIKE ILLNESS (flue like symptoms), PRESYNCOPE (Near syncope), DIZZINESS (feeling lightheaded/ dizziness) and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy).    No treatment information was provided
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Pyrexia, Vaccination site pain, Wheezing
Clinical narrative: Wheezing; Lightheaded; Fever; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING, DIZZINESS, PYREXIA, VACCINATION SITE PAIN, and CHILLS in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol high. Concomitant products included INLYTA for Lung cancer.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced WHEEZING, DIZZINESS, PYREXIA, VACCINATION SITE PAIN, and CHILLS. On 24-Feb-2021, WHEEZING, DIZZINESS, PYREXIA, VACCINATION SITE PAIN, and CHILLS had resolved.            Treatment information not provided
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: Rash over left thigh; White blisters/bubbles over thigh; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash over left thigh) and BLISTER (White blisters/bubbles over thigh) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 07-Mar-2021, the patient experienced RASH (Rash over left thigh) and BLISTER (White blisters/bubbles over thigh). At the time of the report, RASH (Rash over left thigh) and BLISTER (White blisters/bubbles over thigh) outcome was unknown.            No concomitant medications were provided.  Treatment medications were unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness in arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Soreness in arm). At the time of the report, MYALGIA (Soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported  Treatment information was not provided
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Bedridden, Diarrhoea, Pain, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer and describes the occurrence of pain in extremity  (sore arm), pain (body ache), bedridden, diarrhea (loose stool) and vomiting in a 75-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 4, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 4, 2021, patient experienced pain in extremity (sore arm), pain (body ache), bedridden, diarrhea (loose stool), vomiting and pyrexia (fever). The patient treated with Tylenol (paracetamol) for the adverse event(s), at an unspecified dose and frequency. At the time of the report,  pain in extremity (sore arm), pain (body ache), bedridden, diarrhea (loose stool), vomiting and pyrexia (fever) outcome: unknown. Concomitant medications not provided.
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: This spontaneous case reported by a consumer and describes the occurrence of pain in extremity  (sore arm), pain (body ache), bedridden, diarrhea (loose stool) and vomiting in a 75-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 4, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 4, 2021, patient experienced pain in extremity (sore arm), pain (body ache), bedridden, diarrhea (loose stool), vomiting and pyrexia (fever). The patient treated with Tylenol (paracetamol) for the adverse event(s), at an unspecified dose and frequency. At the time of the report,  pain in extremity (sore arm), pain (body ache), bedridden, diarrhea (loose stool), vomiting and pyrexia (fever) outcome: unknown. Concomitant medications not provided.
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: Eye pruritus, Eye swelling, Lacrimation increased
Clinical narrative: itching eyes both; running eyes; swelling eyes; This spontaneous case was reported by an other health care professional and describes the occurrence of EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 06-Mar-2021, the patient experienced EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes). At the time of the report, EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes) to be not applicable.    Concomitant product use was not reported.  Treatment information was not provided.